Speakers
Jürg Burri
Ambassador of SwitzerlandMichał Stępień
President of the Polish - Swiss Chamber of Commerce; Country Head UBS PolandPiotr Arak
Director of the Polish Economic InstituteLiliane Brunner Halbach
Expert in Global Pharma and Life SciencePiotr Dardziński
President of Łukasiewicz Research NetworkBart Dzikowski
Managing Director, Head of Transactions & Legal of Novartis Venture FundNeil Goldsmith
Director Strategy, BaseLaunchJan Krzewiński
President, Polpharma Biologics GdańskJacek Jemielity
President at ExploRNA TherapeuticsJordi Montserrat
Co-Founder and Managing Partner in VenturelabRadosław Sierpiński
Acting President of the Medical Research AgencyMichał Walczak
Co-founder and a Chief Scientific Officer at Captor TherapeuticsIrma Veberič
General Manager Roche PolandMichał Wszoła
Transplantation surgeon, founder and CEO of PolbionicaAgnieszka Sznyk
President of the Board INNOWOPablo Padrutt
Head of Economic, Financial and Scientific Affairs at the Embassy of Switzerland in PolandUlrich Schwendimann
Managing Director of the Polish-Swiss Chamber of CommerceConference agenda
Registration8:30 - 9:00
|
|
Opening Remarks9:00-9:30
H.E. Mr Jürg Burri, Ambasador of Switzerland to Poland (10′) Anna Goławska, Undersecretary of State, Ministry of Health (10′) Michał Stępień, President of the Polish-Swiss Chamber of Commerce (10′) |
|
Keynote Speeches: What are the success factors for innovation in pharma and life sciences in Poland and Switzerland, respectively?9:30-10:15
Piotr Arak, Director of the Polish Economic Institute (15′) (RECORDING) Neil Goldsmith, Director Strategy, BaseLaunch (15′) (RECORDING) Dr Piotr Dardziński, President of Łukasiewicz Research Network (15′) (RECORDING) |
|
Input I: How does Switzerland manage to connect scientists and entrepreneurs to launch and grow biotech companies?10:15-10:30
Jordi Montserrat, Co-Founder and Managing Partner of Venturelab (15′) (RECORDING) |
|
Input II: Building Biotechs – Corporate Venture Capital & Founder/Management Perspectives10:30 - 10:50
Bart Dzikowski, Managing Director, Head of Transactions & Legal of Novartis Venture Fund; board member at UZH Life Sciences Fund, Oculis S.A. and Enterprise Therapeutics Dr Michał Walczak, Co-Founder and Chief Scientific Officer, Captor Therapeutics
|
|
Input III: Personal observations about Poland’s potential from a Swiss expert’s perspective10:50-11:05
Dr Liliane Brunner Halbach, Global Pharma and Life Sciences Expert (15′) |
|
Coffe break11:05 - 11:30
|
|
Panel discussion: How to create an environment conducive to successful R&D in pharma and life sciences11:30-12:20
Irma Veberič, General Manager Roche Poland Dr Radosław Sierpiński, Head of Poland’s Medical Research Agency Jan Krzewiński, President of Polpharma Biologics Gdańsk Prof. Jacek Jemielity, bio-organic chemistry, University of Warsaw Dr hab. Michał Wszola, CEO of Polbionica Ltd., surgeon transplantologist Dr Agnieszka Sznyk, Innowo (moderator)
|
|
Wrapping Up & Conclusions12:20-12:30
Dr inż. Agnieszka Sznyk, Innowo (moderator) |